CompuGroup Medical Acquires Majority Stake in Patient Portal Provider m.Doc

CompuGroup Medical SECompuGroup Medical SE & Co. KGaA has acquired 51% of m.Doc GmbH. m.Doc develops patient portals and digital applications for hospitals, rehabilitation and care facilities. Founded in 2016, the company has offices in Cologne and Lisbon with around 110 employees. CompuGroup Medical will further develop m.Doc's patient portal and integrate it into its systems. CompuGroup Medical will also extend the CLICKDOC solution for appointment booking and video consultations and leverage synergies for messenger solutions. The transaction is an important milestone towards enabling the full digital patient journey in both inpatient and outpatient settings and optimizes referrals from general practitioners to hospitals.

m.Doc focuses on digitizing everyday hospital life, integrating patients into administrative and medical processes before, during and after inpatient treatment, and providing far-reaching relief and support for medical staff. The technical basis for the m.Doc applications is the Smart Health Platform, which connects m.Doc's modular patient portal with services such as video consultations, appointment booking, medication plans, treatment documents and much more. The interoperability of the m.Doc platform with all common hospital information systems will be further promoted for the benefit of customers and partners. m.Doc's vision that everyone can reach their doctor anytime and anywhere via mobile devices fits perfectly with CompuGroup Medical's purpose: "Nobody should suffer or die because at some point medical information was missing."

"The acquisition of m.Doc is an excellent addition to our product portfolio. With m.Doc, we acquire a product suite with an attractive customer base of more than 300 hospitals, making us one of the leading providers in the digital integration of patients into the treatment process in the inpatient sector," emphasizes Hannes Reichl, Managing Director Inpatient and Social Care at CompuGroup Medical SE & Co. KGaA. "Especially in the hospital sector, there is a high demand for new solutions of digital patient communication. This development is gaining additional momentum due to the German Hospital Future Act."

"With CompuGroup Medical, we are entering the next phase of our growth. The financial strength of the group, the large customer base and especially the experience in implementing complex projects are an enormous added value for us as a team and for our customers. In addition, we will work on deep integration with CompuGroup Medical's solutions to offer a fully integrated end-to-end patient journey," says Admir Kulin, Managing Director of m.Doc GmbH, looking positively to the future.

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.130 billion in 2022, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals and social welfare institutions. Its information services for all parties involved in the healthcare system and its webbased personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 20 countries and products in 60 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 9,200 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

Artificial Intelligence: Unexpected Resu…

Artificial intelligence (AI) is on the rise. Until now, AI applications generally have "black box" character: How AI arrives at its results remains hidden. Prof. Dr. Jürgen Bajorath, a cheminformatics...

Printed Robots with Bones, Ligaments, an…

3D printing is advancing rapidly, and the range of materials that can be used has expanded considerably. While the technology was previously limited to fast-curing plastics, it has now been...

AI identifies Non-Smokers at High Risk f…

Using a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer, according to a study being presented next week...

Orchestrating the New World of AI in Hea…

Orion Health's UK and Ireland Customer Conference 2023 focused on the future potential and immediate, practical application of AI to healthcare - and gave delegates a first look at the...

Study Reveals Bias in AI Tools when Diag…

Machine learning algorithms designed to diagnose a common infection that affects women showed a diagnostic bias among ethnic groups, University of Florida researchers found. While artificial intelligence (AI) tools offer...

Researchers Take New AI Approach to Anal…

Researchers at Karolinska Institutet and SciLifeLab in Sweden have combined artificial intelligence (AI) techniques used in satellite imaging and community ecology to interpret large amounts of data from tumour tissue...

Medical AI Tool from UF, NVIDIA gets Hum…

A new artificial intelligence (AI) computer program created by researchers at the University of Florida and NVIDIA can generate doctors' notes so well that two physicians couldn't tell the difference...

Commission Opens Calls to Invest €42 Mil…

Today, the European Commission opened a new set of calls for proposals under the 2023-2024 Work Programmes of the Digital Europe Programme with a focus on advanced digital skills. The calls...

Bayer Championing Advancements in Radiol…

Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline of its investigational contrast agent as well as new innovations in the area of Artificial Intelligence...

MEDICA and COMPAMED: Medical Technology …

13 - 16 November 2023, Düsseldorf, Germany. After four days of business, MEDICA and COMPAMED in Düsseldorf delivered impressive confirmation that they are excellent platforms for the worldwide medical technology business...

AI Predicts Developmental Paths in Prema…

Researchers at UMC Utrecht have developed an AI model to predict long-term outcome in extremely premature babies early in life. The model can identify which infants might face intellectual disability...

AI Paves Way for New Medicines

A team of researchers from LMU, ETH Zurich, and Roche Pharma Research and Early Development (pRED) Basel has used artificial intelligence (AI) to develop an innovative method that predicts the...